Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-obesity Agents”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Testing effectiveness (Phase 2)Study completedNCT00402077
What this trial is testing

Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Who this might be right for
OverweightObesity
AstraZeneca 258
Not applicableLooking for participantsNCT07364175
What this trial is testing

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

Who this might be right for
HypertensionObesity & Overweight
Cambridge University Hospitals NHS Foundation Trust 60
Not applicableLooking for participantsNCT06752018
What this trial is testing

Inflammation's Impact on Heart Disease and Diabetes

Who this might be right for
InflammationObesity and Type 2 DiabetesObesity+2 more
University of Aarhus 250
Testing effectiveness (Phase 2)WithdrawnNCT00735683
What this trial is testing

A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety

Who this might be right for
Obesity
Healios K.K.
Testing effectiveness (Phase 2)Study completedNCT00822705
What this trial is testing

Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36

Who this might be right for
Anti Obesity Agent
University Hospital, Basel, Switzerland 16
Not applicableStudy completedNCT00275834
What this trial is testing

Zonisamide for Weight Reduction in Obese Adults

Who this might be right for
Obesity
Duke University 225
Large-scale testing (Phase 3)Study completedNCT03336086
What this trial is testing

Effect of Weight Reduction on Immunity

Who this might be right for
LymphocytesWeight LossViral Diseases+2 more
Shiraz University of Medical Sciences 29
Post-approval studies (Phase 4)Looking for participantsNCT05975580
What this trial is testing

Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery

Who this might be right for
Obesity
University of California, Irvine 120
Early research (Phase 1)Study completedNCT02259179
What this trial is testing

Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers

Who this might be right for
Healthy
Orexigen Therapeutics, Inc 80
Large-scale testing (Phase 3)Study completedNCT01028976
What this trial is testing

Obesity, Inflammation and Oxidative Stress

Who this might be right for
C-reactive ProteinInflammationObesity+1 more
University of California, Berkeley 512
Post-approval studies (Phase 4)Study completedNCT00044187
What this trial is testing

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Who this might be right for
SchizophreniaPsychotic DisordersBipolar Disorder
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07676331
What this trial is testing

Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

Who this might be right for
Hormone-receptor-positive Breast CancerEarly Breast Cancer
Universitaire Ziekenhuizen KU Leuven 168
Not applicableLooking for participantsNCT07653412
What this trial is testing

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

Who this might be right for
Obesity (Disorder)Anti-obesity AgentsPrecision Medicine
National and Kapodistrian University of Athens 220
Very early researchTemporarily pausedNCT06171152
What this trial is testing

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Who this might be right for
Multiple SclerosisLong COVIDLong Covid19+4 more
University of Chicago 30
Not applicableStudy completedNCT05451927
What this trial is testing

Trial to Examine the Effect of Natural Anti- Obesity Agent (Phaseolus Vulgaris) Among Women of Lahore

Who this might be right for
Overweight and Obesity
Hafiza Aisha Sadiqa 72
Not applicableStudy completedNCT07588750
What this trial is testing

Retrospective Evaluation of Sibutramine-Topiramate Therapy for Obesity in Real-World Outpatient Practice

Who this might be right for
Obesity & Overweight
Falquetomed 278
Early research (Phase 1)Study completedNCT01979380
What this trial is testing

Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Who this might be right for
Drug Toxicity
Kwang Dong Pharmaceutical co., ltd. 40
Early research (Phase 1)Looking for participantsNCT06575738
What this trial is testing

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

Who this might be right for
ObesityAdolescent ObesityBody-Weight Trajectory+3 more
University of Colorado, Denver 40
Testing effectiveness (Phase 2)Study completedNCT05215847
What this trial is testing

Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery

Who this might be right for
Bariatric SurgeryObesityWeight Gain
Aardvark Therapeutics, Inc. 12
Large-scale testing (Phase 3)UnknownNCT00975533
What this trial is testing

Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial

Who this might be right for
Type 2 Diabetes Mellitus
Chinese University of Hong Kong 24
Next Page